Rebamipide AND Sjögren Syndrome
Rebamipide for the Treatment of Xerostomia in Sjögren Syndrome
Sponsor: University of Alexandria
A NA clinical study on Improving Symptoms of Dry Mouth in Sjőgren's Syndrome, this trial is ongoing. The trial is conducted by University of Alexandria and has accumulated 7 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Apr 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Apr 2022 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
▶ Show 2 earlier versions
-
Jan 2019 — Apr 2020 [monthly]
Unknown Status NA
-
Jan 2017 — Jan 2019 [monthly]
Unknown Status NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Alexandria
For direct contact, visit the study record on ClinicalTrials.gov .